Researchers tout PET/CT use in lung cancer treatment

04/21/2013 | Age (Melbourne, Australia), The

Researchers at the Peter MacCallum Cancer Centre in Australia said the use of PET/CT imaging in evaluating patients with advanced lung cancer helped pave the way for significant survival gains. Data gathered from PET/CT scans allowed for tailored treatment that led to a 32% four-year survival rate, up from 10% to 20%. The finding indicates that PET/CT has potential for routine clinical use and that it could also be explored for other cancers, including head and neck cancers, melanoma and some bowel cancers, a researcher said.

View Full Article in:

Age (Melbourne, Australia), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA